ACB
Aurora Cannabis, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$3.87
+0.52%Next report
Analyst consensus
- Next report date
- Nov 4, 2026
- EPS estimate
- -$0.03
- Revenue estimate
- $51.5M
Latest reported
- Last report date
- Aug 5, 2026
- EPS actual
- -$0.05
- EPS estimate
- -$0.13
- Revenue actual
- $47.6M
- Revenue estimate
- $47.4M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +114.3%
- Revenue beats (12Q)
- 2
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 5, 2026 | -$0.13 | -$0.05 | Beat 64.60% | $47.6M |
| Jun 11, 2026 | -$0.07 | $0.07 | Beat 200.00% | $61.0M |
| Feb 4, 2026 | $0.10 | $0.09 | Miss -7.42% | $68.6M |
| Nov 5, 2025 | $0.03 | $0.09 | Beat 200.00% | $63.2M |
| Jun 18, 2025 | $0.11 | $0.07 | Miss -36.36% | $63.3M |
| Feb 5, 2025 | -$0.09 | $0.06 | Beat 166.67% | $61.3M |
| Jun 20, 2024 | -$0.18 | $0.11 | Beat 161.11% | $49.6M |
| Feb 8, 2024 | -$0.10 | -$0.20 | Miss -100.00% | $48.5M |
| Nov 9, 2023 | -$0.25 | -$0.50 | Miss -100.00% | $46.6M |
| Aug 10, 2023 | -$0.80 | -$0.40 | Beat 50.00% | $56.4M |
| Jun 14, 2023 | -$0.40 | -$1.50 | Miss -275.00% | — |
| Feb 9, 2023 | -$0.70 | -$1.40 | Miss -100.00% | $46.0M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 4, 2026